Clever Leaves Holdings Inc (CLVR)
3.00
+0.89
(+42.18%)
USD |
NASDAQ |
May 16, 16:00
2.96
-0.04
(-1.33%)
After-Hours: 20:00
Clever Leaves Holdings Cash from Financing (Quarterly): -0.162M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.162M |
September 30, 2023 | 0.76M |
June 30, 2023 | 0.165M |
March 31, 2023 | -0.107M |
December 31, 2022 | -0.25M |
September 30, 2022 | 3.886M |
June 30, 2022 | -19.04M |
March 31, 2022 | 18.69M |
December 31, 2021 | 0.883M |
September 30, 2021 | -0.585M |
June 30, 2021 | -1.097M |
March 31, 2021 | 2.633M |
Date | Value |
---|---|
December 31, 2020 | 77.21M |
September 30, 2020 | 3.653M |
June 30, 2020 | -5.987M |
March 31, 2020 | 16.97M |
March 31, 2018 | -2.478M |
September 30, 2017 | -2.344M |
June 30, 2017 | -6.855M |
March 31, 2017 | -0.0782M |
September 30, 2016 | -3.598M |
June 30, 2016 | -6.567M |
March 31, 2016 | -3.354M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-19.04M
Minimum
Jun 2022
77.21M
Maximum
Dec 2020
6.101M
Average
0.4625M
Median
Cash from Financing (Quarterly) Benchmarks
Tilray Brands Inc | -10.91M |
Flora Growth Corp | 0.704M |
Acasti Pharma Inc | 0.00 |
Aurinia Pharmaceuticals Inc | -5.577M |
Edesa Biotech Inc | 0.2117M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.543M |
Cash from Investing (Quarterly) | 2.056M |
Free Cash Flow | -11.54M |
Free Cash Flow Per Share (Quarterly) | -0.8019 |
Free Cash Flow to Equity (Quarterly) | -1.269M |
Free Cash Flow to Firm (Quarterly) | -1.364M |
Free Cash Flow Yield | -245.4% |